LLY

1,037.33

-1.17%↓

JNJ

205.1

+0.61%↑

ABBV

229.53

+2.76%↑

UNH

339.22

+4.86%↑

AZN

90.75

+0.63%↑

LLY

1,037.33

-1.17%↓

JNJ

205.1

+0.61%↑

ABBV

229.53

+2.76%↑

UNH

339.22

+4.86%↑

AZN

90.75

+0.63%↑

LLY

1,037.33

-1.17%↓

JNJ

205.1

+0.61%↑

ABBV

229.53

+2.76%↑

UNH

339.22

+4.86%↑

AZN

90.75

+0.63%↑

LLY

1,037.33

-1.17%↓

JNJ

205.1

+0.61%↑

ABBV

229.53

+2.76%↑

UNH

339.22

+4.86%↑

AZN

90.75

+0.63%↑

LLY

1,037.33

-1.17%↓

JNJ

205.1

+0.61%↑

ABBV

229.53

+2.76%↑

UNH

339.22

+4.86%↑

AZN

90.75

+0.63%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Отворен

1.88 0.53

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.81

Максимум

1.92

Ключови измерители
By Trading Economics
Служители	26

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-5M 15M
Предишно отваряне	1.35
Предишно затваряне	1.88

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.12.2025 г., 17:29 ч. UTC

Значими двигатели на пазара

Придобивния, сливания и поглъщания

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2.12.2025 г., 16:21 ч. UTC

Печалби

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2.12.2025 г., 16:18 ч. UTC

Печалби

Correction to Scotiabank Quarterly Earnings Buoyed Article

2.12.2025 г., 23:53 ч. UTC

Пазарно говорене

Nikkei May Rise After Gains on Wall Street -- Market Talk

2.12.2025 г., 22:48 ч. UTC

Печалби

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2.12.2025 г., 22:12 ч. UTC

Пазарно говорене

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2.12.2025 г., 22:03 ч. UTC

Пазарно говорене

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2.12.2025 г., 21:56 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 21:44 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:38 ч. UTC

Пазарно говорене

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2.12.2025 г., 21:19 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 20:06 ч. UTC

Пазарно говорене

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2.12.2025 г., 19:55 ч. UTC

Пазарно говорене

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене

Печалби

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2.12.2025 г., 19:24 ч. UTC

Пазарно говорене

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2.12.2025 г., 19:06 ч. UTC

Пазарно говорене

Precious Metals Step Back After Silver Sets Record -- Market Talk

2.12.2025 г., 18:27 ч. UTC

Придобивния, сливания и поглъщания

Kraken to Acquire Backed Finance AG

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 15:17 ч. UTC

Пазарно говорене

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2.12.2025 г., 14:47 ч. UTC

Пазарно говорене

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2.12.2025 г., 14:38 ч. UTC

Пазарно говорене

Silver Steps Back From Record Levels -- Market Talk

2.12.2025 г., 14:31 ч. UTC

Пазарно говорене

Печалби

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.